News

  • Spinal study paves way for new stem cell therapies

    A recent spinal injury study could lead to new stem cell therapies after rare neurons were found to reconnect damaged spinal circuits and trigger leg muscle activity. Scientists transplanted neural progenitor cells, early-stage cells that can develop into different types of nerve cell, into injured spinal cords in animal models and examined how the transplanted [...]

  • Royal Osteoporosis Society named as Slater and Gordon’s Charity of the Year winner

    National law firm Slater and Gordon is delighted to announce the Royal Osteoporosis Society as its newest Charity of the Year, embarking on a powerful partnership to drive greater awareness and support for people affected by bone health conditions. The initiative launched at the start of this year, building on the success of the firm’s [...]

  • Home programme cuts post-stroke falls

    A home programme cut post-stroke falls by 33 per cent over 12 months, in what researchers said was a world first for a non-drug intervention. The study, known as the Falls After Stroke Trial, found a co-ordinated programme of functional exercise, reducing hazards around the home and coaching on mobility outside the home cut falls [...]

  • Moderate screen time may aid concussion recovery

    Moderate screen time after concussion was linked to greater improvement in psychological symptoms in adolescents than either low or high use, a study suggests. The research followed adolescents aged 12 to 17.9 years who had sustained a concussion, a mild brain injury usually caused by a blow to the head, and were assessed within 10 [...]

  • MS prevalence doubles but survival rates improve, research finds

    MS prevalence in England more than doubled from 2000 to 2020, rising 6 per cent a year, while survival also improved, new research has revealed. The researchers estimated that standardised prevalence rose from 107 per 100,000 people in 2000 to 232 per 100,000 in 2020, equal to about 131,000 people living with MS in 2020. [...]

  • Drug gains orphan status for spinal cord therapy

    A spinal cord therapy being developed by a Universitat Autònoma de Barcelona (UAB) team has gained EMA orphan status, which could help speed its development. The designation means the compound, based on the bioactive lipid molecule Maresin-1 (MaR1), could offer relevant clinical benefit in an area of high unmet medical need. Spinal cord [...]

  • Judge rebukes rugby brain injury legal teams over lack of progress

    A judge has again criticised both sides in the rugby brain injury cases as two landmark claims continue to make little progress. Senior master Jeremy Cook opened the latest case management hearings by reminding both defendants and claimants that "it won't have escaped anybody's notice that some of these claims are now over five years [...]

  • Blood test may predict decline after cardiac arrest

    A blood test taken 48 hours after cardiac arrest could help predict a survivor's long-term memory and thinking, researchers say. The study found that measuring neurofilament light chain, or NfL, was significantly better at predicting later memory and thinking problems than the blood marker now used by doctors. NfL is a protein released into the [...]

  • Clot buster may stop promising stroke medicine from working properly

    A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need to test new stroke therapies alongside existing standard care. According to The University of Manchester led study on mice, the timing of anakinra must be adjusted to avoid reducing the benefits of the clot‑busting therapy known [...]

  • Blood test predicts stroke 15 years before onset

    A blood test could predict stroke and other cardiovascular diseases up to 15 years before symptoms appear, researchers say. The tool, called CardiOmicScore, uses a single blood sample to generate personalised risk scores for six major cardiovascular conditions: coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral artery disease and venous thromboembolism. The [...]